Medicare Enrolled
Dr. Samir Sutaria, MD
Nephrology · Edison, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sutaria from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sutaria?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sutaria
Dr. Samir Sutaria is a nephrology specialist in Edison, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sutaria performed 3,619 Medicare services across 1,679 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sutaria received a total of $8,822 from 45 pharmaceutical and/or device companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sutaria is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in NJ
$8,822 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,619
Medicare services
Top 12% in NJ for nephrology
1,679
Unique beneficiaries
$122
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~181 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
866 | $104 | $250 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
653 | $69 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
553 | $106 | $200 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
384 | $304 | $500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
240 | $152 | $400 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
217 | $62 | $250 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
135 | $66 | $250 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
128 | $184 | $500 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
94 | $72 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $143 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
65 | $155 | $200 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
60 | $249 | $450 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
49 | $13 | $86 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
31 | $44 | $100 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
31 | $35 | $80 |
| Chronic kidney disease education session A one-hour individual educational session focused on the care of chronic kidney disease. |
30 | $58 | $75 |
| New patient office visit, complex (60-74 min) | 14 | $171 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,822
Total received (2018-2024)
Avg $1,260/year across 7 years
Top 7% in NJ for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
433
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,597 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$225 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,217
2023
$920
2022
$1,974
2021
$1,812
2020
$765
2019
$1,550
2018
$584
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ANI Pharmaceuticals, Inc.
$257
Bayer Healthcare Pharmaceuticals Inc.
$134
ABBVIE INC.
$125
Amgen Inc.
$125
AstraZeneca Pharmaceuticals LP
$100
Vifor Pharma, Inc.
$96
Dexcom, Inc.
$83
OPKO Pharmaceuticals, LLC
$76
GlaxoSmithKline, LLC.
$64
AKEBIA THERAPEUTICS INC
$43
Fresenius USA Marketing, Inc.
$36
Novo Nordisk Inc
$28
Aurinia Pharma U.S., Inc.
$17
Novartis Pharmaceuticals Corporation
$17
CALLIDITAS THERAPEUTICS US INC.
$16
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,385
Novo Nordisk Inc
$731
Amgen Inc.
$614
Fresenius USA Marketing, Inc.
$489
GlaxoSmithKline, LLC.
$431
Vifor Pharma, Inc.
$371
ANI Pharmaceuticals, Inc.
$333
Daiichi Sankyo Inc.
$292
OPKO Pharmaceuticals, LLC
$285
Mallinckrodt Hospital Products Inc.
$279
Janssen Pharmaceuticals, Inc
$267
AKEBIA THERAPEUTICS INC
$263
Novartis Pharmaceuticals Corporation
$262
Otsuka America Pharmaceutical, Inc.
$236
Bayer Healthcare Pharmaceuticals Inc.
$204
Alexion Pharmaceuticals, Inc.
$182
Calliditas Therapeutics US Inc.
$177
Lilly USA, LLC
$177
Horizon Therapeutics plc
$171
Aurinia Pharma U.S., Inc.
$167
Bayer HealthCare Pharmaceuticals Inc.
$156
ABBVIE INC.
$125
GENZYME CORPORATION
$125
Ambu Inc.
$118
Relypsa, Inc.
$112
Exeltis, USA Inc.
$105
Ultragenyx Pharmaceutical Inc.
$102
CALLIDITAS THERAPEUTICS US INC.
$94
Dexcom, Inc.
$83
Medtronic MiniMed, Inc.
$83
Allergan Inc.
$63
Intuitive Surgical, Inc.
$55
Mallinckrodt Enterprises LLC
$48
Keryx Biopharmaceuticals, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$40
ARBOR PHARMACEUTICALS, INC.
$27
Otsuka Pharmaceutical Development & Commercialization, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$15
Travere Therapeutics, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Kowa Pharmaceuticals America, Inc.
$13
AbbVie Inc.
$13
Shire North American Group Inc
$12
Merck Sharp & Dohme Corporation
$12
Baxter Healthcare
$11
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AURYXIA · Auryxia · BASAGLAR · BENLYSTA · BYSTOLIC · Bidil · Crysvita · DEXCOM G7 GSS (161) · DUPIXENT · Da Vinci Surgical System · ENTRESTO · EVUSHELD · Edarbi · FARXIGA · Fabhalta · GATTEX · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · JESDUVROQ · JYNARQUE · KORSUVA · KRYSTEXXA · Kerendia · Korsuva · LINZESS · LOKELMA · LUPKYNIS · Livalo · Otezla · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · RINVOQ · RYBELSUS · Renal - CRRT · Rybelsus · SAMSCA · SOLIRIS · TARPEYO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tavneos · Thiola · Tresiba · Vafseo · Velphoro · Veltassa · Victoza · Wegovy · XARELTO · Xultophy 100/3.6 · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for nephrology in NJ.
Geographic Context
Nephrologists within 10 mi
351
Per 100K population
40.7
County median income
$109,028
Nearest hospital
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sutaria is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NJ), with low-engagement industry engagement in the top 7% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sutaria experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Sutaria performed 866 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sutaria receive payments from pharmaceutical companies?
Yes. Dr. Sutaria received a total of $8,822 from 45 companies across 433 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sutaria's costs compare to other nephrologists in Edison?
Dr. Sutaria's average Medicare payment per service is $122. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sutaria) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Edison
Browse nephrologists in Edison ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NJ
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NJ
Which NJ nephrologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology